Gynaecological Infections & STDs

Rapid testing, guideline-based treatment and partner management with discreet, compassionate care

Book Infections & STDs Consultation

24–48 hrs

Typical report turnaround

Pap/HPV and NAAT results routed to EMR with SMS alerts

85–92%

Symptom resolution at 7–14 days

With guideline-based therapy and adherence

90%+

Partner treatment completion

Via counselling, take-home guidance and reminders

When to Consult

•Foul-smelling discharge, itching, burning or swelling
•Painful urination, lower abdominal pain or fever (possible PID)
•Bleeding after sex or between periods; contact pain
•Sores, warts or blisters in the genital area
•New partner, unprotected sex or partner with symptoms
•Persistent/recurrent symptoms despite OTC treatment

Understanding Infections & STDs in the Indian Context

In Hyderabad and across Telangana, many women try home remedies for discharge or itching before seeking care, which can delay accurate diagnosis. Using FOGSI/NACO-aligned protocols, Ajuda offers rapid testing, discreet counselling and partner treatment to stop symptoms and prevent recurrence.

When to Consult Our Infection Specialists

✓ Foul discharge, itching or burning
✓ Painful urination, fever or lower abdominal pain
✓ Bleeding after sex or between periods
✓ Genital sores, blisters or warts
✓ New partner, unprotected sex or partner with symptoms
✓ Symptoms persisting despite OTC treatment

Our Diagnostic Approach

Syndromic Assessment & Pregnancy Rule-Out

History, exam and pregnancy test guide safe therapy choices.

Point-of-Care Microscopy & pH

Wet mount/KOH, pH and whiff test differentiate BV/yeast/trichomonas.

Lab Testing

NAAT for chlamydia/gonorrhoea; Pap/HPV and serology (HIV, syphilis) when risk factors exist.

Imaging & Escalation

Ultrasound for PID/TOA suspicion; admission and IV antibiotics for severe cases or pregnancy with acute infection.

Treatment Pathways

We start empirical therapy after samples and refine to culture/NAAT results. BV/yeast/trichomonas protocols are standardised; STIs receive NAAT-guided antibiotics or antivirals. PID has a clear outpatient/IV pathway. Pregnancy-safe regimens are used when expecting. Partner evaluation and vaccination (HPV, Hep-B) reduce reinfection. Tele/WhatsApp follow-ups confirm adherence and test-of-cure.

What to Expect: Your Care Journey

Visit 1: evaluation, samples and treatment start. Results are shared in 24–48 hours. A 48–72-hour check ensures improvement; dose adjustments are made if needed. At 2–6 weeks we confirm cure and reinforce prevention. Annual recalls keep screening and vaccination on track.

Technology & Innovation

NAAT platforms improve detection for chlamydia/gonorrhoea. Digital EMR with SMS/WhatsApp reminders reduces loss-to-follow-up and supports partner care. Imaging access helps identify PID early and avoid complications.

Preventing Complications

Early, correct treatment prevents infertility, ectopic pregnancy, chronic pelvic pain and recurrent infections. Barrier protection, vaccination and partner management are the strongest tools against reinfection.

Why Ajuda for Infection Care?

🧪 Rapid NAAT testing & fast reports

🤝 Discreet partner treatment & counselling

💬 Multilingual care with cashless support

Take the First Step

Don’t wait with uncomfortable symptoms. Call 9010550550 or message on WhatsApp to get fast, discreet treatment today.

Diagnosis Approach

Syndromic assessment & pregnancy rule-out

FOGSI/NACO-aligned history and exam; urine/serum pregnancy test before certain medicines.

Point-of-care microscopy & pH testing

Wet mount/KOH, vaginal pH and whiff test to differentiate BV, candidiasis and trichomoniasis.

Laboratory testing

NAAT for chlamydia/gonorrhoea; Pap/HPV as indicated; VDRL/RPR, HIV, HBsAg and HCV when risk factors present.

Imaging & escalation

Ultrasound for suspected PID/TOA; admission if severe pain, high fever or pregnancy with acute infection.

Treatment Options

Rapid Testing & Same-Day Treatment

Empirical therapy started post-samples; refined to culture/NAAT results for targeted cure.

Shortens time to symptom relief and reduces complications.

Initiation on Day 0; review at 48–72 hrs

Targeted BV/Yeast/Trichomonas Care

Metronidazole/tinidazole for BV/trichomonas; topical/oral azoles for candidiasis with recurrence protocols.

High cure rates with correct diagnosis and adherence.

Single-dose to 7–14 days; maintenance if recurrent

STI Protocols (Chlamydia/Gonorrhoea/HSV)

NAAT-guided antibiotics; episodic or suppressive antivirals for HSV; test-of-cure where indicated.

Reduces transmission and long-term sequelae.

As per regimen with follow-up at 2–6 weeks

PID Pathway

Outpatient dual therapy with close review; IV antibiotics and admission for severe illness or pregnancy.

Prevents infertility, ectopic pregnancy and chronic pelvic pain.

14 days typical; imaging-guided escalation

Pregnancy-Safe Infection Care

Trimester-safe drugs, fetal monitoring and coordination with obstetrics; avoid teratogenic agents.

Symptom control with maternal-fetal safety.

Course-based with antenatal follow-ups

Partner Management & Prevention

Partner evaluation/treatment, condom counselling, HPV/Hep-B vaccination and recurrence prevention.

Cuts reinfection; improves long-term control.

Initiate Day 0; reinforce at 2–6 weeks

Expected Outcomes

Treatment Timeline

2–4 Weeks

Symptoms settled; partner treatment documented; test-of-cure scheduled if indicated.

6–8 Weeks

No reinfection; Pap/HPV or serology reviews completed where needed.

3–6 Months

Recurrence prevention plan active; contraception/STI counselling reinforced.

1 Year+

Annual screening reminders and vaccination completion.

Success Metrics

Symptom-free at 14 days
Partner treatment completion rate
Reinfection rate within 6 months

Get Fast, Discreet Care for Infections

Emergency

9010550550

contact@ajudahospitals.in

Related Services

Cervical Cancer Screening & Vaccination

Screening and HPV vaccination lower long-term risk.

Uro-Gynaecology

Recurrent UTIs and pelvic symptoms may overlap.